Skip to content
FIND A HEALTH VALLEY ACTOR

Artiria Medical, Planny and Algorized receive support from FIT

FIT-artiria-planny-algorized

The three startups have received financial support from the Foundation for technological innovation (FIT). Artiria Medical gets a Tech Growth loan to treat strokes Artiria Medical, a leader in medical device innovation for neurovascular treatments, receives a CHF 500,000 Tech Growth Loan. Their unique deflectable wire technology, which significantly improves the accuracy and speed of…

Read More

Dopamine production is not behind vulnerability to cocaine abuse

Dopamine

A UNIGE team shows that our ability to produce dopamine – the «happiness hormone» – is not correlated with increased vulnerability to drugs.     Why do some people who try drugs struggle with substance abuse while others don’t? This question has long puzzled scientists. A team from the University of Geneva (UNIGE) explored the…

Read More

Agora Care celebrates 10’000 patients and a new collaboration with Caduceo

The Campus biotech startup, recruited over 10’000 patients on its Agora Care platform.     This marks an inflection point of the acceleration of Agora Care patient recruitment from early pilot projects to extended recruitment in several large radiology and healthcare networks in Switzerland. Agora Care is developing a patient-centered platform for storage and communication…

Read More

FONGIT Innovation Fund (FIF) awards funding to Geneva-based tech projects

FONGIT FIF

A seed loan of CHF 100,000 has been granted to previous FIF Grant laureate and HUG spinoff HeroSupport. One grant of CHF 50,000 has been awarded to HUG project SmellRS.     The FIF supports innovative technological startups and scale-ups at different stages of their journey with three types of financing options: the FIF Grant…

Read More

Artiria Medical successfully secures USD 6 Million

Artiria Medical

Artiria Medical secures funding to complete its clinical studies in stroke in both Europe and the Us, following promising first in-human results and FDA clearance.     The MedTech company, developing next-generation neuro-interventional products for stroke and aneurysms, successfully closed off a Series A2 round of USD 0.6 Million. Furthermore, they secured an additional USD…

Read More

Leenaards Prize awarded to two CHUV research groups

Leenaards prize

The two Leenards scientific prizes were awarded to research groups led by CHUV researchers.     Each year, the Leenards Foundation awards scientific prizes for projects combining basic and clinical research, carried out by research groups in the Lake Geneva region. For 2024, a total of nearly CHF 1.4 million has been awarded to the…

Read More

NewBiologix announced a licensing agreement with Florabio AS

New Biologix - licensing

NewBiologix SA announced a licensing agreement with Florabio AS to genetically engineer their proprietary HEK293 cell line.     NewBiologix’s innovative approach stands to replace the industry-standard transient transfection methods, offering a stable, more reliable, and scalable solution for biopharmaceutical companies developing gene therapies. Under the terms of the agreement, NewBiologix acquired rights to use…

Read More

Aktiia secures CHF 27 Million

Aktiaa secures 27M

The Neuchâtel-based startup secures CHF 27 Million (USD 30M) in funding from Khosla Ventures and Others.     Aktiia mission to revolutionise blood pressure monitoring has gained momentum with the successful closing of our CHF 27 million (USD 30 million) funding round, which was led by Redalpine and included participation from an international investor syndicate…

Read More

Future of Health Grant unveils its March 2024 cohort

Future of health march 204

Startups Resilient SA and Maven Health are among the eight new startups selected by the Future of Health Grant (FoHG) programme.   Launched in 2022 by CSS and EPFL Innovation Park to support innovation in digital health, the programme received over 130 applications in its latest call for applications. The eight selected startups will receive…

Read More

Argá Medtech SA closes oversubscribed Series B

ArgaMedtech-series b

Argá Medtech announces €54 Million oversubscribed series B capital raise.     The round was led by the existing investors, Advent Life Sciences (UK) and Earlybird Health (Germany), as well as new investor Gilde Healthcare (the Netherlands) and an undisclosed strategic investor. The financing enables Argá Medtech to advance the development of its innovative CSE™…

Read More